Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis.

Gut - 1 Sept 2015

Li Peiwei, Wu Han, Zhang Honghe, Shi Yu, Xu Jinming, Ye Yao, Xia Dajing, Yang Jun, Cai Jianting, Wu Yihua

Abstract excerpt

OBJECTIVE: The objective of this meta-analysis was to systematically assess the survival benefit of aspirin use before or after diagnosis for patients with colorectal cancer (CRC). DESIGN: Relevant studies were identified through searching PubMed, Embase and Cochrane databases before May 2014. Two investigators extracted data independently for baseline characteristics and outcomes from the included studies....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Aspirin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cause of Death

Share to Class I Phosphatidylinositol 3-Kinases

Share to Cyclooxygenase 2

Share to Drug Administration Schedule

Share to Phosphatidylinositol 3-Kinases

Share to Randomized Controlled Trials as Topic

Source

Identifiers

PMID: 25239119
DOI: 10.1136/gutjnl-2014-308260

Genes

PTGS2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis.PMID 25239119Read ↗

PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies.Semantic proximity Read ↗

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.Semantic proximity Read ↗

Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort StudySemantic proximity Read ↗

Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer.Semantic proximity Read ↗

Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer.Semantic proximity Read ↗

The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis.Semantic proximity Read ↗

Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation.Semantic proximity Read ↗

Adjuvant aspirin and Cyclooxygenase-2 inhibitors in resected, PIK3CA-mutated colorectal cancer: A systematic review and meta-analysis of randomized controlled trials.Semantic proximity Read ↗

Aspirin use and risk of colorectal cancer according to BRAF mutation status.Semantic proximity Read ↗

Aspirin and Cancer: An Updated MinireviewSemantic proximity Read ↗

The Protective Effects of Aspirin Use from Adverse In Hospital Outcomes and Metastatic Disease in Colorectal Cancer: An Evaluation of the National Inpatient SampleSemantic proximity Read ↗

Potential biomarker for aspirin use in colorectal cancer therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.